Index RUT
P/E -
EPS (ttm) -0.88
Insider Own 53.62%
Shs Outstand 82.83M
Perf Week 0.30%
Market Cap 809.12M
Forward P/E -
EPS next Y -0.47
Insider Trans -0.57%
Shs Float 38.75M
Perf Month 110.04%
Income -72.77M
PEG -
EPS next Q -0.12
Inst Own 48.37%
Short Float 17.49%
Perf Quarter 19.95%
Sales 245.00M
P/S 3.30
EPS this Y -11.82%
Inst Trans 11.71%
Short Ratio 12.57
Perf Half Y 28.39%
Book/sh 1.67
P/B 6.02
EPS next Y 27.75%
ROA -24.45%
Short Interest 6.78M
Perf Year -1.08%
Cash/sh 0.49
P/C 20.67
EPS next 5Y 29.80%
ROE -43.68%
52W Range 4.65 - 14.79
Perf YTD -19.23%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -29.18%
52W High -32.12%
Beta 1.39
Dividend TTM -
Quick Ratio 1.60
Sales past 5Y 19.90%
Gross Margin 64.26%
52W Low 115.91%
ATR (14) 0.66
Dividend Ex-Date -
Current Ratio 3.50
EPS Y/Y TTM -3.89%
Oper. Margin -22.01%
RSI (14) 71.08
Volatility 6.67% 8.89%
Employees 574
Debt/Eq 0.79
Sales Y/Y TTM 18.16%
Profit Margin -29.70%
Recom 1.00
Target Price 14.33
Option/Short Yes / Yes
LT Debt/Eq 0.79
EPS Q/Q -46.28%
Payout -
Rel Volume 1.69
Prev Close 10.43
Sales Surprise 2.89%
EPS Surprise 3.85%
Sales Q/Q 18.10%
Earnings Nov 12 AMC
Avg Volume 539.19K
Price 10.04
SMA20 28.22%
SMA50 49.61%
SMA200 19.88%
Trades
Volume 909,821
Change -3.74%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-29-23 Initiated
William Blair
Outperform
Apr-11-23 Initiated
Stephens
Overweight
$23
Dec-14-22 Resumed
B. Riley Securities
Buy
$32
Nov-19-24 05:45AM
Nov-18-24 09:00AM
Nov-15-24 09:55AM
Nov-13-24 02:19AM
Nov-12-24 06:05PM
04:05PM
Loading…
04:05PM
Nov-11-24 07:14AM
Nov-01-24 05:45AM
Oct-30-24 07:14AM
Oct-17-24 04:42PM
04:05PM
Oct-16-24 04:05PM
11:20AM
Oct-09-24 06:00PM
10:00AM
08:00AM
Loading…
Oct-02-24 08:00AM
Sep-30-24 02:34PM
Sep-25-24 09:00PM
02:17PM
Sep-17-24 08:38AM
Sep-16-24 09:00PM
Sep-11-24 06:32AM
Sep-10-24 09:00AM
Sep-09-24 05:37PM
Sep-05-24 06:32AM
(Medical Device Network) -12.22%
Sep-04-24 09:15AM
Sep-03-24 09:00PM
12:53PM
Aug-28-24 11:58AM
Aug-26-24 09:00PM
04:13PM
Loading…
04:13PM
Aug-22-24 02:27PM
Aug-20-24 07:31AM
Aug-19-24 04:41PM
Aug-14-24 05:36PM
(GlobeNewswire) -5.53%
+7.56%
07:00AM
Aug-13-24 02:49PM
Aug-12-24 09:00PM
Aug-11-24 11:13AM
Aug-08-24 09:58PM
(InvestorPlace) +5.19%
-20.10%
04:10PM
12:17PM
10:00AM
Aug-05-24 03:26PM
Aug-02-24 03:56PM
Aug-01-24 07:13PM
Jul-17-24 04:05PM
May-13-24 10:30AM
May-10-24 02:36PM
May-09-24 10:16AM
07:46AM
(Thomson Reuters StreetEvents)
May-08-24 10:55PM
04:05PM
May-02-24 04:05PM
Apr-04-24 11:43AM
08:01AM
Apr-01-24 10:32AM
Mar-28-24 04:05PM
04:58AM
Mar-02-24 08:54AM
Mar-01-24 06:44AM
(Thomson Reuters StreetEvents) -5.77%
Feb-29-24 04:35PM
04:05PM
Feb-12-24 11:36AM
Feb-06-24 04:05PM
Feb-01-24 08:00AM
Jan-30-24 04:43PM
Jan-26-24 08:00AM
Jan-17-24 08:00AM
Jan-08-24 09:00AM
Jan-05-24 08:00AM
Dec-19-23 04:05PM
Nov-20-23 10:34AM
Nov-16-23 11:31AM
Nov-14-23 04:05PM
08:00AM
Nov-13-23 04:05PM
Nov-12-23 08:55AM
Nov-08-23 08:45AM
(Thomson Reuters StreetEvents) -7.15%
Nov-07-23 04:05PM
04:05PM
Nov-06-23 06:42AM
Nov-03-23 08:00AM
Oct-17-23 04:05PM
Sep-11-23 07:00AM
Aug-28-23 04:05PM
Aug-02-23 05:25PM
04:05PM
Jul-28-23 08:00AM
Jul-27-23 08:35AM
Jul-12-23 04:05PM
Jun-12-23 06:34AM
May-23-23 08:00AM
May-05-23 08:42AM
(Thomson Reuters StreetEvents)
May-04-23 06:55PM
04:05PM
Apr-26-23 04:05PM
Apr-24-23 04:05PM
Apr-20-23 04:05PM
Apr-18-23 05:35PM
Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. Its products include bone graft harvest system, bone marrow aspirate kits, and soft tissue fixation system. The company was founded by Albert DaCosta, Frank Bono, Jim Riegler and Lee Rosenthal in 2010 and is headquartered in Englewood, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MVM Partners, LLC 10% Owner Nov 22 '24 Proposed Sale 10.43 200,000 2,086,000 Nov 22 05:11 PM MVM Partners, LLC 10% Owner Nov 20 '24 Sale 10.28 147,581 1,517,133 10,738,564 Nov 22 04:27 PM MVM Partners, LLC 10% Owner Nov 21 '24 Sale 10.41 107,366 1,117,680 10,631,198 Nov 22 04:27 PM Piper Sandler Merchant Banking Director Nov 22 '24 Proposed Sale 10.43 32,277 336,649 Nov 22 04:03 PM Piper Sandler Merchant Banking Director Nov 21 '24 Proposed Sale 10.35 50,000 517,500 Nov 21 04:31 PM MVM Partners, LLC 10% Owner Nov 20 '24 Proposed Sale 10.50 300,000 3,150,000 Nov 20 04:41 PM Piper Sandler Merchant Banking Director Nov 19 '24 Proposed Sale 10.20 397,500 4,054,500 Nov 19 04:39 PM WRIGHT KRISTINA Director Nov 13 '24 Sale 10.00 4,181 41,810 34,478 Nov 15 04:02 PM KRISTINA WRIGHT Director Nov 13 '24 Proposed Sale 7.50 4,181 31,358 Nov 13 04:26 PM DaCosta Albert See Remarks Mar 15 '24 Buy 9.12 28,000 255,226 5,339,110 Mar 18 05:34 PM
Index -
P/E -
EPS (ttm) -1.53
Insider Own 27.02%
Shs Outstand 27.29M
Perf Week 14.63%
Market Cap 102.30M
Forward P/E -
EPS next Y -0.54
Insider Trans 0.00%
Shs Float 19.91M
Perf Month -6.47%
Income -41.95M
PEG -
EPS next Q -0.19
Inst Own 66.43%
Short Float 0.07%
Perf Quarter -32.13%
Sales 84.71M
P/S 1.21
EPS this Y 27.39%
Inst Trans 55.52%
Short Ratio 0.12
Perf Half Y -31.14%
Book/sh 0.36
P/B 5.23
EPS next Y 55.05%
ROA -28.62%
Short Interest 0.01M
Perf Year -41.07%
Cash/sh 0.91
P/C 2.08
EPS next 5Y -
ROE -240.82%
52W Range 1.55 - 4.64
Perf YTD -52.28%
Dividend Est. -
P/FCF -
EPS past 5Y 21.65%
ROI -59.58%
52W High -59.48%
Beta 0.43
Dividend TTM -
Quick Ratio 1.45
Sales past 5Y 34.90%
Gross Margin 56.18%
52W Low 21.29%
ATR (14) 0.13
Dividend Ex-Date -
Current Ratio 1.54
EPS Y/Y TTM 44.99%
Oper. Margin -31.20%
RSI (14) 47.87
Volatility 9.31% 7.53%
Employees 300
Debt/Eq 3.26
Sales Y/Y TTM -
Profit Margin -49.52%
Recom 1.00
Target Price 6.04
Option/Short No / Yes
LT Debt/Eq 3.14
EPS Q/Q -7.67%
Payout -
Rel Volume 1.75
Prev Close 1.71
Sales Surprise 8.39%
EPS Surprise -48.20%
Sales Q/Q 20.50%
Earnings Nov 06 AMC
Avg Volume 120.26K
Price 1.88
SMA20 -1.31%
SMA50 -8.88%
SMA200 -28.66%
Trades
Volume 210,926
Change 9.94%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-31-24 Initiated
Lake Street
Buy
$7
May-31-23 Initiated
TD Cowen
Outperform
$7
Jul-18-22 Resumed
Oppenheimer
Outperform
$18
Nov-07-24 02:29AM
Nov-06-24 04:00PM
Nov-05-24 08:08AM
Oct-28-24 05:01PM
Oct-14-24 08:00AM
09:31PM
Loading…
Sep-25-24 09:31PM
04:05PM
Aug-21-24 08:53PM
04:00PM
Aug-12-24 04:00PM
Jul-08-24 08:00AM
08:00AM
May-15-24 04:00PM
May-06-24 08:52AM
May-01-24 01:53PM
07:45AM
Loading…
07:45AM
Mar-28-24 01:30PM
Mar-12-24 04:00PM
(GlobeNewswire) -8.77%
+10.00%
Mar-07-24 10:42AM
Mar-06-24 04:00PM
Feb-21-24 05:00PM
Feb-16-24 08:45AM
Jan-08-24 04:00PM
Dec-18-23 01:00AM
Nov-27-23 01:00AM
Nov-14-23 04:00PM
Nov-13-23 04:00PM
Nov-08-23 04:00PM
Nov-06-23 01:00AM
Oct-25-23 04:00PM
04:00PM
Loading…
Oct-20-23 04:00PM
Oct-09-23 04:00PM
Oct-02-23 04:04PM
(GlobeNewswire) -8.57%
-10.94%
Sep-26-23 04:46PM
Aug-23-23 04:00PM
Aug-10-23 04:00PM
Aug-09-23 04:00PM
Aug-03-23 07:25PM
Jun-30-23 04:00PM
Jun-05-23 05:30PM
May-25-23 04:30PM
(GlobeNewswire) -7.55%
+7.58%
May-23-23 04:00PM
May-15-23 04:00PM
May-01-23 04:00PM
Apr-25-23 04:00PM
Apr-19-23 04:00PM
Apr-07-23 04:30PM
Mar-13-23 02:00AM
Mar-08-23 05:00PM
04:00PM
Mar-06-23 05:34PM
Mar-03-23 04:30PM
Feb-28-23 04:30PM
Feb-22-23 04:30PM
Feb-21-23 04:30PM
Feb-15-23 04:30PM
Feb-13-23 04:00PM
Feb-03-23 08:00AM
Feb-01-23 04:00PM
Jan-20-23 01:00AM
Jan-09-23 04:00PM
Dec-19-22 05:00PM
Nov-29-22 04:06PM
Nov-04-22 01:33PM
(American City Business Journals) -7.64%
Oct-27-22 04:00PM
Aug-25-22 04:00PM
Aug-19-22 04:00PM
Aug-09-22 10:09AM
Aug-02-22 04:30PM
(Thomson Reuters StreetEvents)
+12.90%
04:00PM
May-25-22 04:00PM
May-19-22 04:00PM
Apr-27-22 04:00PM
Apr-25-22 04:00PM
Mar-30-22 04:30PM
Mar-02-22 04:00PM
Feb-17-22 04:00PM
Feb-09-22 04:00PM
Dec-10-21 06:01PM
Nov-22-21 05:00PM
Nov-15-21 05:00PM
Nov-09-21 03:38PM
MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, Europe and Rest of the World. The firm offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite